Annual report pursuant to Section 13 and 15(d)

Condensed Consolidated Statements Of Operations

v3.21.2
Condensed Consolidated Statements Of Operations - USD ($)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
REVENUES:    
Sales $ 267,584 $ 673,919
Related party Sales 13,069 21,157
Total Revenues 280,653 695,076
Cost of sales 159,304 248,556
Gross Profit 121,349 446,520
OPERATING EXPENSES:    
Depreciation 5,933 7,299
Selling and marketing 420,511 1,743,427
Payroll and related 411,954 385,246
Stock-based compensation 3,014,888 1,417,850
General and administrative 1,122,954 3,363,516
Total operating expenses 4,976,240 6,917,338
Net loss from operations (4,854,891) (6,470,818)
OTHER INCOME (EXPENSES):    
Interest expense, net (2,999,291) (4,682,247)
Legal Contingency expense 0 (1,497,674)
Impairment gain (Loss) on Joint Ventures (22,658) (478,400)
Income (loss) on equity investment 106,305 (13,842)
Loss on change in fair value of derivative liabilities (4,698,072) (2,123,570)
Unrealized Gain (loss) on trading securities 248,204 (677,584)
Realized loss on sale of trading securities (2,603) (75,545)
Loss on disposition of investment 0 (389,664)
(Loss) Gain on settlement of debt 77,624 (3,770,974)
Total other income (expense) (7,290,491) (13,709,500)
Net loss before income taxes (12,145,382) (20,180,318)
Income taxes (benefit) 0 0
NET INCOME (LOSS) $ (12,145,382) $ (20,180,318)
Loss per common share, basic and diluted $ (0.01) $ (0.41)
Weighted average number of common shares outstanding, basic and diluted (after stock-split) 962,029,388 48,669,683